Market Place
Sourcing Support
Pulmocide exits OPERA with evidence of antifungal efficacy
15 Apr 2024 //
FIERCE BIOTECH
Pulmocide OPERA-S Inhaled Opelconazole Phase 2 Positive Results
15 Apr 2024 //
GLOBENEWSWIRE
Pulmocide Announces Data Confirming Low Potential for Inhaled Opelconazole
16 Oct 2023 //
GLOBENEWSWIRE
Pulmocide Announces Expansion of Management Team
08 Jun 2023 //
GLOBENEWSWIRE
Pulmocide Raises $52 Mto Fund Additional Late-Stage Devp of Opelconazole
06 Dec 2022 //
GLOBENEWSWIRE
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug
14 Sep 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.